ERFSF — Stock activity · TradeandTellERFS
ERFSF
$81.69-$0.79 (-0.96%)live
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$64.95 – $86.20
79% from low
Held by traders on TradeandTell
No one on the platform currently holds ERFSF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ERFSF as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 2.23% ($1.82/share)
| Ex-date | Per share | Pay date |
|---|
| 2026-04-29 | $0.7200 | 2026-04-30 |
| 2025-04-29 | $0.6000 | 2025-04-30 |
| 2024-07-03 | $0.5000 | 2024-07-05 |
Stock splits
| Execution date | Ratio |
|---|
| 2020-11-27 | 10-for-1 |
Recent trades on TradeandTell
No one on the platform has traded ERFSF yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2026 | $7.5B | +2.0% | $3.82 | $3.75–$3.93 | 21.4× | 1 |
| 2027 | $7.9B | +5.5% | $4.37 | $4.29–$4.49 | 18.7× | 1 |
| 2028 | $8.4B | +6.7% | $4.95 | $4.86–$5.08 | 16.5× | 1 |
| 2029 | $9.3B | +10.6% | $5.56 | $5.46–$5.71 | 14.7× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2026-07-23 | $2.18 | $2.39 | +9.6% |
| 2026-01-29 | $1.48 | $1.50 | +1.4% |
| 2025-07-23 | $2.01 | $1.93 | -4.0% |
| 2025-01-30 | $1.54 | $1.39 | -9.7% |
| 2024-07-24 | $1.59 | $1.76 | +10.7% |
| 2024-02-27 | $1.32 | $0.95 | -28.1% |
| 2023-07-26 | $1.38 | $1.48 | +7.2% |
| 2023-03-01 | $1.59 |
DCF fair valuemodel estimate
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| ERFSFEurofins Scientific SE | $81.69 | -0.96% | $14.1B | — |
| BDUUYBangkok Dusit Medical Services Public Company Limited | $23.30 | +0.00% | $9.3B | — |
| BIOVFSwedish Orphan Biovitrum AB (publ) | $48.20 | +0.00% | $16.7B | — |
| BMXMFbioMérieux S.A. | $82.66 | +4.65% | $9.8B | — |
| CHEOFCochlear Limited | $93.00 |
| CHEOYCochlear Limited | $46.82 | -0.28% | $6.1B | — |
| CHJTFCSPC Pharmaceutical Group Limited | $1.07 | +0.00% | $12.2B | — |
Source: Financial Modeling Prep · peers by sector/industry